eLetters is an online forum for ongoing peer review. Submission of eLetters are open to all. Please read our Terms of Service before submitting your own eLetter.
Research ArticleCell Biology
Bimolecular complementation affinity purification (BiCAP) reveals dimer-specific protein interactions for ERBB2 dimers
- David R. Croucher1,2,3,*,
- Mary Iconomou1,†,
- Jordan F. Hastings1,†,
- Sean P. Kennedy1,4,†,
- Jeremy Z. R. Han1,
- Robert F. Shearer1,
- Jessie McKenna1,
- Adrian Wan5,
- Joseph Lau5,
- Samuel Aparicio5,6, and
- Darren N. Saunders1,7,*
- 1The Kinghorn Cancer Centre, Garvan Institute of Medical Research, Sydney, New South Wales 2010, Australia.
- 2St. Vincent’s Hospital Clinical School, University of New South Wales, Sydney, New South Wales 2052, Australia.
- 3School of Medicine, University College Dublin, Belfield, Dublin D4, Ireland.
- 4Systems Biology Ireland, University College Dublin, Belfield, Dublin D4, Ireland.
- 5Department of Molecular Oncology, British Columbia Cancer Research Centre, Vancouver, British Columbia V5Z 1L3, Canada.
- 6Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia V6T 1Z4, Canada.
- 7School of Medical Sciences, University of New South Wales, Sydney, New South Wales 2052, Australia.
- ↵*Corresponding author. Email: d.croucher{at}garvan.org.au (D.R.C.); d.saunders{at}unsw.edu.au (D.N.S.)
↵† These authors contributed equally to this work.
See allHide authors and affiliations
Science Signaling 12 Jul 2016:
Vol. 9, Issue 436, pp. ra69
DOI: 10.1126/scisignal.aaf0793
Vol. 9, Issue 436, pp. ra69
DOI: 10.1126/scisignal.aaf0793
David R. Croucher
1The Kinghorn Cancer Centre, Garvan Institute of Medical Research, Sydney, New South Wales 2010, Australia.
2St. Vincent’s Hospital Clinical School, University of New South Wales, Sydney, New South Wales 2052, Australia.
3School of Medicine, University College Dublin, Belfield, Dublin D4, Ireland.
Mary Iconomou
1The Kinghorn Cancer Centre, Garvan Institute of Medical Research, Sydney, New South Wales 2010, Australia.
Jordan F. Hastings
1The Kinghorn Cancer Centre, Garvan Institute of Medical Research, Sydney, New South Wales 2010, Australia.
Sean P. Kennedy
1The Kinghorn Cancer Centre, Garvan Institute of Medical Research, Sydney, New South Wales 2010, Australia.
4Systems Biology Ireland, University College Dublin, Belfield, Dublin D4, Ireland.
Jeremy Z. R. Han
1The Kinghorn Cancer Centre, Garvan Institute of Medical Research, Sydney, New South Wales 2010, Australia.
Robert F. Shearer
1The Kinghorn Cancer Centre, Garvan Institute of Medical Research, Sydney, New South Wales 2010, Australia.
Jessie McKenna
1The Kinghorn Cancer Centre, Garvan Institute of Medical Research, Sydney, New South Wales 2010, Australia.
Adrian Wan
5Department of Molecular Oncology, British Columbia Cancer Research Centre, Vancouver, British Columbia V5Z 1L3, Canada.
Joseph Lau
5Department of Molecular Oncology, British Columbia Cancer Research Centre, Vancouver, British Columbia V5Z 1L3, Canada.
Samuel Aparicio
5Department of Molecular Oncology, British Columbia Cancer Research Centre, Vancouver, British Columbia V5Z 1L3, Canada.
6Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia V6T 1Z4, Canada.
Darren N. Saunders
1The Kinghorn Cancer Centre, Garvan Institute of Medical Research, Sydney, New South Wales 2010, Australia.
7School of Medical Sciences, University of New South Wales, Sydney, New South Wales 2052, Australia.
Submit a Response to This Article
No eLetters have been published for this article.